Skip to main
STAA

STAAR Surgical (STAA) Stock Forecast & Price Target

STAAR Surgical (STAA) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 13%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Staar Surgical is expected to benefit from favorable market conditions, continued demand for their innovative ICL products, and expansion into new international markets. Additionally, the recent launch of their EVO Viva ICL in Europe bodes well for future revenue growth. With positive momentum and a strong financial position, the company is well-positioned for long-term success.

Bears say

Staar Surgical is currently overvalued due to a combination of factors: 1) increased revenue estimates for FY'26 that rely heavily on China's rebound, despite management's cautious outlook and lack of formal guidance, 2) inflated valuation multiples compared to its peers and industry benchmarks, and 3) a lack of visibility into future numbers that could potentially impact long-term growth. Additionally, while the recent 1Q'26 results showed strong performance, there are concerns about the potential for a significant downturn in the overall market demand for Staar's ICL products, which account for the majority of its revenue.

STAAR Surgical (STAA) has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 13% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STAAR Surgical (STAA) Forecast

Analysts have given STAAR Surgical (STAA) a Buy based on their latest research and market trends.

According to 8 analysts, STAAR Surgical (STAA) has a Buy consensus rating as of Jun 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $29.69, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $29.69, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STAAR Surgical (STAA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.